The Claim
Daily administration of the selective adenosine A(2A) receptor antagonist SCH58261 at a dose of 0.5 mg/kg for four days produces the same protective effect against cognitive impairment induced by beta-amyloid (25-35) in mice as daily administration of caffeine over the same period.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice, a special drug called SCH58261, given daily for four days, works just as well as coffee to protect the brain from memory problems caused by a harmful protein.
See the scientific wording
The selective adenosine A(2A) receptor antagonist SCH58261 (0.5 mg/kg) produces the same protective effect against beta-amyloid (25-35)-induced cognitive impairment in mice as caffeine, when administered daily for four days.
What the research says
1 studyThe study found that a drug called SCH58261 worked just as well as caffeine at helping mice remember things after being exposed to a brain-toxic protein — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.